Document is current
Any future updates will be listed below
-
Authors
Choi, Maia https://orcid.org/0009-0007-9918-4901
Aliev, Fazil
Barr, Peter B. https://orcid.org/0000-0001-9321-657X
Cooke, Megan E.
Kuo, Sally I. https://orcid.org/0000-0002-6192-1001
Salvatore, Jessica E. https://orcid.org/0000-0001-5504-5087
Dick, Danielle M.
Brislin, Sarah J. https://orcid.org/0000-0003-4303-8124
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R21MH126130)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K23DA058808, R01DA050721, R01DA050721)
- License Information
-
More Information
Article History
Received: 13 August 2024
Revised: 13 May 2025
Accepted: 19 June 2025
First Online: 5 July 2025
Ethics approval and consent to participate
: All procedures of the ABCD Study were approved by a central Institutional Review Board (IRB) at the University of California, San Diego, and as well as by an individual site IRB at Rutgers University (Pro2022001743). Parents of guardians provided written informed consent after the ABCD Study procedures had been fully explained and the children assented before participation. All methods were performed in accordance with the relevant guidelines and regulations.
: Dr. Dick is a co-founder of Thrive Genetics, Inc, and a member of the advisory board of Seek Health Group, Inc. She owns stock in both companies. All other authors have reported no biomedical financial interests or potential conflicts of interest.
